Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D

NCT05252728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 372

Last updated 2023-07-11

No results posted yet for this study

Summary

To elucidate the characteristics of global gut microbiota and fecal/serum metabolites in patients with childhood-onset type 1 diabetes, adult-onset type 1 diabetes or type 2 diabetes.

Conditions

  • Type 1 Diabetes Mellitus Maturity Onset

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • Yang Xiao, MD/PhD · Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, China

Eligibility

Min Age
5 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252728 on ClinicalTrials.gov